Shigehiro Fujimoto
About
In The Last Decade
Shigehiro Fujimoto
19 papers receiving 307 citations
Peers
Comparison fields: 5 of 69
- Endocrinology, Diabetes and Metabolism 135
- Genetics 107
- Molecular Biology 95
- Surgery 40
- Immunology 40
Countries citing papers authored by Shigehiro Fujimoto
This map shows the geographic impact of Shigehiro Fujimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigehiro Fujimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigehiro Fujimoto more than expected).
Fields of papers citing papers by Shigehiro Fujimoto
This network shows the impact of papers produced by Shigehiro Fujimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigehiro Fujimoto. The network helps show where Shigehiro Fujimoto may publish in the future.
Co-authorship network of co-authors of Shigehiro Fujimoto
This figure shows the co-authorship network connecting the top 25 collaborators of Shigehiro Fujimoto. A scholar is included among the top collaborators of Shigehiro Fujimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigehiro Fujimoto. Shigehiro Fujimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 42 | |
| 3 | 13 | |
| 4 | [Clinical result of intraperitoneal hyperthermic chemoperfusion for gastric cancer with serosal invasion to prevent peritoneal recurrence]. | 3 |
| 5 | 19 | |
| 6 | 125 | |
| 7 | [The experimental and clinical study of hyperthermia with thermosensitizer for gastric cancer patients with peritoneal seeding]. | 3 |
| 8 | 32 | |
| 9 | 13 | |
| 10 | 4 | |
| 11 | Albumin microspheres as drug carriers. | 36 |
| 12 | 3 | |
| 13 | 6 | |
| 14 | [Effect of albumin pH on ionized calcium (Ca++) determination. 2]. | 1 |
| 15 | 6 | |
| 16 | [Clinical evaluation of schizophyllan (SPG) in advanced gastric cancer--a randomized comparative study by an envelope method]. | 12 |
| 17 | 3 | |
| 18 | 9 | |
| 19 | Clinical value of fecal CEA as an aid to diagnosis. | 5 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.